From a traditional medicine monomer to a modern neurotherapeutic scaffold: a review of SAR-Driven tetramethylpyrazine derivatives for cerebrovascular and cognitive health

Tetramethylpyrazine (TMP), a bioactive alkaloid isolated from the traditional Chinese medicine Ligusticum wallichii (Chuanxiong), has gained significant attention for its therapeutic potential in cerebrovascular diseases and cognitive impairment, mainly due to its antioxidant, anti-inflammatory, and...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaodi Wang, Muhan Cao, Yi Xu, Xifei Yang, Qinghua Hou
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-08-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1653056/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849231599532507136
author Xiaodi Wang
Muhan Cao
Yi Xu
Xifei Yang
Qinghua Hou
author_facet Xiaodi Wang
Muhan Cao
Yi Xu
Xifei Yang
Qinghua Hou
author_sort Xiaodi Wang
collection DOAJ
description Tetramethylpyrazine (TMP), a bioactive alkaloid isolated from the traditional Chinese medicine Ligusticum wallichii (Chuanxiong), has gained significant attention for its therapeutic potential in cerebrovascular diseases and cognitive impairment, mainly due to its antioxidant, anti-inflammatory, and anti-apoptotic properties. However, its clinical application is often limited by suboptimal pharmacokinetic characteristics and modest potency. This review highlights recent advancements in the structure-activity relationship (SAR) optimization of TMP, focusing on its derivatives’ neuroprotective efficacy and vascular benefits. We specifically emphasize the clinical translational potential of several TMP derivatives, such as T-006, TMP-nitrone hybrids (e.g., TN-2), TMP-piperazine derivatives, and TMP-phenolic acid hybrids (e.g., T-VA). These compounds exhibit markedly improved drug-like properties, including enhanced lipid solubility, oral bioavailability, blood-brain barrier (BBB) permeability, and multi-target neuroprotective actions. Additionally, we critically examine the challenges these TMP derivatives face in clinical translation, such as metabolic instability, hepatotoxicity, and formulation challenges, while discussing current strategies to address these issues. The review concludes by emphasizing the significant promise of these next-generation TMP derivatives as therapeutic candidates for cerebrovascular and neurodegenerative disorders, and their need for further preclinical and clinical exploration to fully realize their therapeutic potential.
format Article
id doaj-art-de216a945e0747efb2f24fddde1b4b0b
institution Kabale University
issn 1663-9812
language English
publishDate 2025-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj-art-de216a945e0747efb2f24fddde1b4b0b2025-08-21T05:27:33ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-08-011610.3389/fphar.2025.16530561653056From a traditional medicine monomer to a modern neurotherapeutic scaffold: a review of SAR-Driven tetramethylpyrazine derivatives for cerebrovascular and cognitive healthXiaodi Wang0Muhan Cao1Yi Xu2Xifei Yang3Qinghua Hou4Department of Neurology, Clinical Neuroscience Center, The 7th Affiliated Hospital, Sun Yat-Sen University, Shenzhen, ChinaDepartment of Neurology, Clinical Neuroscience Center, The 7th Affiliated Hospital, Sun Yat-Sen University, Shenzhen, ChinaDepartment of Rehabilitation Medicine, The 7th Affiliated Hospital, Sun Yat-Sen University, Shenzhen, ChinaShenzhen Key Laboratory of Modern Toxicology, Shenzhen Medical Key Discipline of Health Toxicology (2020-2024), Shenzhen Center for Disease Control and Prevention, Shenzhen, ChinaDepartment of Neurology, Clinical Neuroscience Center, The 7th Affiliated Hospital, Sun Yat-Sen University, Shenzhen, ChinaTetramethylpyrazine (TMP), a bioactive alkaloid isolated from the traditional Chinese medicine Ligusticum wallichii (Chuanxiong), has gained significant attention for its therapeutic potential in cerebrovascular diseases and cognitive impairment, mainly due to its antioxidant, anti-inflammatory, and anti-apoptotic properties. However, its clinical application is often limited by suboptimal pharmacokinetic characteristics and modest potency. This review highlights recent advancements in the structure-activity relationship (SAR) optimization of TMP, focusing on its derivatives’ neuroprotective efficacy and vascular benefits. We specifically emphasize the clinical translational potential of several TMP derivatives, such as T-006, TMP-nitrone hybrids (e.g., TN-2), TMP-piperazine derivatives, and TMP-phenolic acid hybrids (e.g., T-VA). These compounds exhibit markedly improved drug-like properties, including enhanced lipid solubility, oral bioavailability, blood-brain barrier (BBB) permeability, and multi-target neuroprotective actions. Additionally, we critically examine the challenges these TMP derivatives face in clinical translation, such as metabolic instability, hepatotoxicity, and formulation challenges, while discussing current strategies to address these issues. The review concludes by emphasizing the significant promise of these next-generation TMP derivatives as therapeutic candidates for cerebrovascular and neurodegenerative disorders, and their need for further preclinical and clinical exploration to fully realize their therapeutic potential.https://www.frontiersin.org/articles/10.3389/fphar.2025.1653056/fulltetramethylpyrazinepharmacologypharmacodynamicsstructure-activity relationshipscerebrovascular functioncognition
spellingShingle Xiaodi Wang
Muhan Cao
Yi Xu
Xifei Yang
Qinghua Hou
From a traditional medicine monomer to a modern neurotherapeutic scaffold: a review of SAR-Driven tetramethylpyrazine derivatives for cerebrovascular and cognitive health
Frontiers in Pharmacology
tetramethylpyrazine
pharmacology
pharmacodynamics
structure-activity relationships
cerebrovascular function
cognition
title From a traditional medicine monomer to a modern neurotherapeutic scaffold: a review of SAR-Driven tetramethylpyrazine derivatives for cerebrovascular and cognitive health
title_full From a traditional medicine monomer to a modern neurotherapeutic scaffold: a review of SAR-Driven tetramethylpyrazine derivatives for cerebrovascular and cognitive health
title_fullStr From a traditional medicine monomer to a modern neurotherapeutic scaffold: a review of SAR-Driven tetramethylpyrazine derivatives for cerebrovascular and cognitive health
title_full_unstemmed From a traditional medicine monomer to a modern neurotherapeutic scaffold: a review of SAR-Driven tetramethylpyrazine derivatives for cerebrovascular and cognitive health
title_short From a traditional medicine monomer to a modern neurotherapeutic scaffold: a review of SAR-Driven tetramethylpyrazine derivatives for cerebrovascular and cognitive health
title_sort from a traditional medicine monomer to a modern neurotherapeutic scaffold a review of sar driven tetramethylpyrazine derivatives for cerebrovascular and cognitive health
topic tetramethylpyrazine
pharmacology
pharmacodynamics
structure-activity relationships
cerebrovascular function
cognition
url https://www.frontiersin.org/articles/10.3389/fphar.2025.1653056/full
work_keys_str_mv AT xiaodiwang fromatraditionalmedicinemonomertoamodernneurotherapeuticscaffoldareviewofsardriventetramethylpyrazinederivativesforcerebrovascularandcognitivehealth
AT muhancao fromatraditionalmedicinemonomertoamodernneurotherapeuticscaffoldareviewofsardriventetramethylpyrazinederivativesforcerebrovascularandcognitivehealth
AT yixu fromatraditionalmedicinemonomertoamodernneurotherapeuticscaffoldareviewofsardriventetramethylpyrazinederivativesforcerebrovascularandcognitivehealth
AT xifeiyang fromatraditionalmedicinemonomertoamodernneurotherapeuticscaffoldareviewofsardriventetramethylpyrazinederivativesforcerebrovascularandcognitivehealth
AT qinghuahou fromatraditionalmedicinemonomertoamodernneurotherapeuticscaffoldareviewofsardriventetramethylpyrazinederivativesforcerebrovascularandcognitivehealth